申请人:ISTITUTO DE ANGELI S.p.A.
公开号:EP0309422A3
公开(公告)日:1990-01-10
New pharmacologically active amidino tricycle derivatives as muscarinic receptor blocking agents, useful for the treatment of gastrointestinal disorders of the following formula:
wherein
R represents a hydrogen atom or a halogen atom
X represents nitrogen or -CH-group
W represents a -NH-CO-, -CH=CH-, -CH₂-CH₂- group, oxygen or sulfur
R₁ represents a hydrogen atom or a C₁₋₄ alkyl group
n is 0 or 1
Y represents sulfur or a -CH- group
A represents carbon or nitrogen
B represents a -CH- group (provided that A is different from nitrogen), -COO-, -CO-, or -CH₂- group
m is 0 or an integer from 1 to 3
Z represents -NH-, -CO-, -COO- or -CH- group, or it is absent
p is 0 or 1
Het represents piperazinyl, homopiperazinyl, piperidinyl, tropyl or tetrahydropirimidinyl group, each group being optionally substituted by a C₁₋₄ alkyl group or an amino group
q is 0 or 1
R₂ represents a hydrogen atom, a C₁₋₄ alkyl group or an amino group optionally substituted by a linear or branched C₁₋₄ alkyl group or phenyl group
R₃ represents a linear or branched C₁₋₈alkyl group or a hydrogen atom (provided that the bond between Het and the group
is a carbon- carbon bond or A=C and B=CH), or
R₂ and R₃ may join together to form a heterocyclic 5-membered ring, tautomers thereof and acid addition salts of the aforesaid compounds.The process for the preparation of the compounds of formula (I) as well as pharmaceuticals compositions containing them are also described.
新的药理活性的氨基甲酰三环衍生物作为胆碱能受体阻滞剂,用于治疗以下化学式的胃肠道疾病:其中R代表氢原子或卤素原子,X代表氮或-CH-基团,W代表-NH-CO-,-CH=CH-,-CH₂-CH₂-基团,氧或硫,R₁代表氢原子或C₁₋₄烷基,n为0或1,Y代表硫或-CH-基团,A代表碳或氮,B代表-CH-基团(前提是A不同于氮),-COO-,-CO-或-CH₂-基团,m为0或1至3的整数,Z代表-NH-,-CO-,-COO-或-CH-基团,或者它不存在,p为0或1,Het代表哌嗪基,同型哌嗪基,吡啶基,茄樟基或四氢吡咯基团,每个基团可以选择地被C₁₋₄烷基或氨基基团取代,q为0或1,R₂代表氢原子,C₁₋₄烷基或氨基基团,可以选择地被线性或支链C₁₋₄烷基或苯基取代,R₃代表线性或支链C₁₋₈烷基或氢原子(前提是Het和基团之间的键是碳-碳键或A=C且B=CH),或R₂和R₃可以结合形成杂环5-成员环,其互变异构体和上述化合物的酸加成盐的制备过程以及含有它们的药物组成物也被描述。